UK markets close in 6 minutes

Medifast, Inc. (0K05.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
19.10-0.20 (-1.05%)
As of 04:07PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-65.28%
S&P500 52-week change 323.95%
52-week high 3109.46
52-week low 319.10
50-day moving average 351.19
200-day moving average 372.86

Share statistics

Avg vol (3-month) 3450
Avg vol (10-day) 3355
Shares outstanding 511.96M
Implied shares outstanding 6N/A
Float 89.64M
% held by insiders 12.55%
% held by institutions 1104.90%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 33.30
Trailing annual dividend yield 317.10%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.55%
Operating margin (ttm)5.29%

Management effectiveness

Return on assets (ttm)16.44%
Return on equity (ttm)35.49%

Income statement

Revenue (ttm)897.81M
Revenue per share (ttm)82.40
Quarterly revenue growth (yoy)-49.90%
Gross profit (ttm)N/A
EBITDA 95.53M
Net income avi to common (ttm)67.76M
Diluted EPS (ttm)14.02
Quarterly earnings growth (yoy)-79.20%

Balance sheet

Total cash (mrq)156.43M
Total cash per share (mrq)14.63
Total debt (mrq)20.57M
Total debt/equity (mrq)9.75%
Current ratio (mrq)2.85
Book value per share (mrq)19.73

Cash flow statement

Operating cash flow (ttm)90.88M
Levered free cash flow (ttm)56.58M